Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
97,395,258
-
Shares change
-
+7,473,701
-
Total reported value, excl. options
-
$477,415,251
-
Value change
-
+$38,514,658
-
Put/Call ratio
-
69%
-
Number of buys
-
93
-
Number of sells
-
68
-
Price
-
$4.90
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2022
As of 30 Sep 2022 SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) had 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 97,395,258 shares of stock of the company.
Largest 10 holders included BlackRock Inc., WASATCH ADVISORS INC, VANGUARD GROUP INC, STATE STREET CORP, CREDIT SUISSE AG/, Nuveen Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, Rokos Capital Management LLP, GEODE CAPITAL MANAGEMENT, LLC, and Avidity Partners Management LP.
This table shows 189 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.